SB408 - Maryland Department of Health - Reports on Standing Orders and Opioid Overdose Reversal Drugs
Maryland - 2024 Regular Session
Introduced byKatherine Ann Klausmeier
Last updated 5 months ago
1 Co-Sponsor
Requiring the Maryland Department of Health to report, on or before December 1, 2024, December 1, 2025, and December 1, 2026, to the Senate Finance Committee and the House Health and Government Operations Committee on current opioid overdose reversal drugs approved by the federal Food and Drug Administration and, for any approved opioid overdose reversal drug, whether the Department has added the drug to a standing order and, if not, the reasons why the drug has not been added.
STATUS
Passed
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity nowError
You must be a resident or registered voter in this state.